Skyler Johnson, MD
Skyler Johnson, MD
University of Utah Huntsman Cancer Institute
Verified email at - Homepage
Cited by
Cited by
Use of alternative medicine for cancer and its impact on survival
SB Johnson, HS Park, CP Gross, JB Yu
JNCI: Journal of the National Cancer Institute 110 (1), 121-124, 2018
Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers
SB Johnson, HS Park, CP Gross, BY James
JAMA oncology 4 (10), 1375-1381, 2018
Cancer misinformation and harmful information on Facebook and other social media: a brief report
SB Johnson, M Parsons, T Dorff, MS Moran, JH Ward, SA Cohen, ...
JNCI: Journal of the National Cancer Institute 114 (7), 1036-1039, 2022
Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information
SB Johnson, AJ King, EL Warner, S Aneja, BH Kann, CL Bylund
JNCI cancer spectrum 7 (2), pkad015, 2023
Radiosurgery for brain metastases: changing practice patterns and disparities in the United States
BH Kann, HS Park, SB Johnson, VL Chiang, BY James
Journal of the National Comprehensive Cancer Network 15 (12), 1494-1502, 2017
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer
DA Hamstra, MH Stenmark, T Ritter, D Litzenberg, W Jackson, S Johnson, ...
International Journal of Radiation Oncology* Biology* Physics 85 (5), 1246-1253, 2013
Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following …
W Jackson, DA Hamstra, S Johnson, J Zhou, B Foster, C Foster, D Li, ...
Cancer 119 (18), 3287-3294, 2013
MDM2 inhibition sensitizes prostate cancer cells to androgen ablation and radiotherapy in a p53-dependent manner
FY Feng, Y Zhang, V Kothari, JR Evans, WC Jackson, W Chen, ...
Neoplasia 18 (4), 213-222, 2016
Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer
MH Stenmark, ASC Conlon, S Johnson, S Daignault, D Litzenberg, ...
Radiotherapy and Oncology 110 (2), 291-297, 2014
The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy
DA Hamstra, SB Johnson, S Daignault, BJ Zikmund-Fisher, JMG Taylor, ...
Medical Decision Making 35 (1), 27-36, 2015
Brachytherapy boost utilization and survival in unfavorable-risk prostate cancer
SB Johnson, NH Lester-Coll, JR Kelly, BH Kann, BY James, SK Nath
European Urology 72 (5), 738-744, 2017
Duration of androgen deprivation therapy influences outcomes for patients receiving radiation therapy following radical prostatectomy
WC Jackson, MJ Schipper, SB Johnson, C Foster, D Li, HM Sandler, ...
European urology 69 (1), 50-57, 2016
A prostate-specific antigen doubling time of< 6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post …
WC Jackson, SB Johnson, D Li, C Foster, B Foster, Y Song, M Schipper, ...
Radiation Oncology 8, 1-8, 2013
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
SB Johnson, PR Soulos, TD Shafman, CA Mantz, AP Dosoretz, R Ross, ...
Radiotherapy and oncology 121 (2), 294-298, 2016
Overall survival is improved when DCIS accompanies invasive breast cancer
AJ Kole, HS Park, SB Johnson, JR Kelly, MS Moran, AA Patel
Scientific reports 9 (1), 9934, 2019
The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer
S Johnson, W Jackson, D Li, Y Song, C Foster, B Foster, J Zhou, ...
International Journal of Radiation Oncology* Biology* Physics 86 (3), 554-561, 2013
SB Johnson, M Parsons, T Dorff, MS Moran, JH Ward
P., Pine, DS, Klein, DF, Kasen, S., & Brook, JS, 2348-2351, 2000
Changes in length and complexity of clinical practice guidelines in oncology, 1996-2019
BH Kann, SB Johnson, HJWL Aerts, RH Mak, PL Nguyen
JAMA Network Open 3 (3), e200841-e200841, 2020
Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following …
WC Jackson, SB Johnson, B Foster, C Foster, D Li, Y Song, J Vainshtein, ...
Practical radiation oncology 4 (2), 99-107, 2014
What is the alternative? Responding strategically to cancer misinformation
JS Peterson, B Swire-Thompson, SB Johnson
Future oncology 16 (25), 1883-1888, 2020
The system can't perform the operation now. Try again later.
Articles 1–20